You have 9 free searches left this month | for more free features.

Condition

Anemia (1)

Breast Diseases (1)

Breast Neoplasms (1)

Drug/Agent Toxicity by Tissue/Organ (1)

Lung Cancer (1)

Metastases, Neoplasm (1)

Neutropenia (1)

Overall Status

Completed (2)

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

BioNumerik Pharmaceuticals, Inc. (1)

Collaborator

Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019. (1)

National Cancer Institute (NCI) (1)

Intervention

bnp7787 (2)

cisplatin (1)

darbepoetin alfa (1)

docetaxel (1)

pegfilgrastim (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

bnp7787

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Breast Tumors, Breast Diseases, Metastases, Tumor Trial (BNP7787, Placebo)

Completed

Breast Neoplasms
+2 more

BNP7787
Placebo

(no location specified)

Jul 11, 2022

Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer Trial in United States (darbepoetin alfa, pegfilgrastim, cisplatin)

Completed

Anemia
+3 more

darbepoetin alfa
+4 more

Mountain View, California
+63 more

Jun 28, 2016